pubmed.ncbi.nlm.nih.gov

Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] RSS feed

Get the latest updates from Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] directly as they happen.

Follow now 162 followers

About this feed

Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]: Latest results from PubMed

Status: Working Checked 9 minutes ago, every 10 minutes
Posts: Less than once a week Last post 1 day ago
Language: English
Followers: 162
Website: pubmed.ncbi.nlm.nih.gov
RSS feed URL: https://pubmed.ncbi.nlm.nih.gov/rss/search/1LecT5S6a3BKTViC3XE36MTgvOhvMs22VdmFujlkIwHyxszAmz/?limit=15&utm_campaign=pubmed-2&fc=20250523035035

Check this feed in the RSS validator

Find the RSS feed of another site

Latest posts

Get Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] where you read

Follow in Feeder Read it with everything else you follow, on the web, iPhone and Android. Email newsletters Turn your reading into a newsletter, without leaving Feeder. RSS to Telegram Your feeds, delivered to Telegram. Feed your AI Connect Claude, ChatGPT and Cursor to your feeds over MCP AI summaries Get the gist, with the sources to check it. Text-to-speech Turn your reading list into a podcast.

Questions

What is the RSS feed URL for Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]?

The feed address is https://pubmed.ncbi.nlm.nih.gov/rss/search/1LecT5S6a3BKTViC3XE36MTgvOhvMs22VdmFujlkIwHyxszAmz/?limit=15&utm_campaign=pubmed-2&fc=20250523035035. Paste it into any RSS reader, or click Follow now to read it in Feeder.

How often does Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] post?

Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] posts less than once a week. The last post was 1 day ago.

Is the Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] RSS feed working?

Yes. Feeder checked it 9 minutes ago and the feed answered normally.

How do I follow Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] in Feeder?

Click Follow now, and sign up if you have no account yet. Feeder's free plan covers up to 200 feeds, on the web, iPhone and Android. No credit card required.

Follow Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] in Feeder

Feeder's free plan covers up to 200 feeds, on the web, iPhone and Android. No credit card required.

Or log in